PRESS-RELEASE ·Filed Jun 4, 2026
Press release · Announcement
Actionable Insight • Neutral
The deal adds a speculative quantum analytics angle but no near-term revenue. Monitor for any future CliniQuantum milestones that could trigger earn-outs.
Final — all horizons settled through T+60d ⚠ clustered
SPRC ▼ -42.98% at T+60d
NEUTRAL call -42.98% · α vs SPY -44.86% · entry $11.54 → $6.58
T+1d
-0.87%
call -0.87% · α +1.73%
$11.44
settled 5mo ago
T+5d
-19.32%
call -19.32% · α -16.77%
$9.31
settled 5mo ago
T+20d
-58.58%
call -58.58% · α -57.21%
$4.78
settled 4mo ago
T+60d
-42.98%
call -42.98% · α -44.86%
$6.58
settled 8w ago
Price Chart
Loading chart...
Executive Summary
SciSparc's majority-owned subsidiary NeuroThera closed its acquisition of a ~54% interest in CliniQuantum for ~CAD$9.5M in stock, with potential earn-out payments up to US$2.5M.
Key Financial Metrics
Deal Value
$9.5M
Key Facts
- NeuroThera acquired ~54% of CliniQuantum for ~CAD$9.5M in stock (56.6M shares).
- Earn-out payments up to US$2.5M contingent on patent filings and fundraising milestones.
- CliniQuantum holds a license for quantum simulation technology applied to clinical trial data.
- SciSparc's market cap is ~$5M; the deal is small relative to the parent company's size.
Financial Impact
Consideration of ~CAD$9.5M in NeuroThera shares; earn-out up to US$2.5M over 3 years. No cash outlay.
dilutionshare count
Risk Factors
- Dilution from NeuroThera share issuance to CliniQuantum sellers.
- Earn-out milestones may never be achieved; no guaranteed return.
- SPRC's low liquidity and small market cap amplify volatility on any news.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3306664 |
27 reports for SPRC
67% Hit rate @ T+5 Went positive at some point 3 of 3 best @ T+5▲ +40.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $1.29 | awaiting T+5 | — | $1.29 (−0.04%) |
Oct 23, 2026 3d ago | 6-K | $1.09 | awaiting T+5 | — | $1.29 (+18.35%) |
Oct 22, 2026 4d ago | Press Release | $1.20 | awaiting T+5 | — | $1.29 (+7.50%) |
Oct 15, 2026 11d ago | 6-K | $2.00 $1.20 | ▲ +40.00% | ▲ +38.99% | $1.29 (+35.50%) |
Oct 15, 2026 11d ago | 6-K | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $1.29 (−35.50%) |
Oct 15, 2026 11d ago | Press Release | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $1.29 (−35.50%) |
Oct 7, 2026 19d ago | 6-K | $4.64 $3.63 | ▼ −21.77% | ▼ −20.79% | $1.29 (−72.20%) |
Sep 30, 2026 26d ago | 6-K | $4.55 $4.43 | ▲ +2.64% | ▲ +3.94% | $1.29 (+71.65%) |
Sep 24, 2026 4w ago | 6-K | $5.39 $4.55 | ▼ −15.58% | ▼ −15.17% | $1.29 (−76.07%) |
Sep 23, 2026 4w ago | Press Release | $5.01 $4.72 | ▼ −5.79% | ▼ −5.11% | $1.29 (−74.25%) |
Showing 10 of 27
US Market Status
Market Closed — Opens in 2h 31m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers